How to contact the center
HCP Center
Gießen Campus of UKGM is a primary care clinic integrating the full spectrum of medical subspecialities and linked to highest standard research facilities of the Medical Faculty of Justus –Liebig University. The full spectrum of opthalmological care is provided at the Department of Ophthalmology.
Special centers
The Department of Ophthalmology provides a long standing expertise in paediatric ophthalmology and neurophthalmological care and research with a dedication in rare and hereditary eye disorders. Interdisciplinary cooperation with several disciplines provides a full spectrum support.
Maintenance
Close links with patient self support organizations provides and promotes patient self-care skills, taking into account their individual physical, psychological and social needs and resources. Caregivers provide or take care of the care as needed. The dignity of the patient and the right to self-determination are thereby fully guaranteed.
Picture : Studio ThD
Contact
Universitätsklinikum Gießen und Marburg GmbH, Gießen, Germany
Team
MD PhD Lyubomyr Lytvynchuk
Germany
PD Dr Markus Preising
Germany
Dr Christoph Friedburg
Germany
Clinical trials
An Open-Label, Dose Escalation and Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Tolerability of Sepofarsen in Pediatric Subjects G (p.Cys998X) Mutation.
A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression: (INTERCEPT-AMD)
A Phase 1, Open-Label, Multi-Center, Dose-Escalating, Safety and Tolerability Study of a Single Intravitreal Injection of AAVCAGsCD59 in Patients With Advanced Non-Exudative (Dry) Age-Related Macular Degeneration With Geographic Atrophy
Long-term need of the drug ranibizumab applied as injection into the eye with or without early targeted peripheral laser photocoagulation of the retina for treatment of macular edema due to central retinal vein occlusion
A double-masked, randomized, controlled, multiple-dose study to evaluate the efficacy, safety, tolerability and systemic exposure of QR-110 in Subjects with Leber’s Congenital Amaurosis (LCA) due to c.2991+1655A>G mutation (p.Cys998X) in the CEP290 gene (Illuminate).
Historical Case Record Survey of Visual Acuity Data From Patients With Leber’s Hereditary Optic Neuropathy (LHON).
A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)